23.3 C
Vientiane
Thursday, February 27, 2025
spot_img

Cision PR Newswire

AIM Vaccine’s mRNA RSV Vaccine Approved for U.S. Clinical Trials

Innovation and Global Expansion Attract Capital Reassessment AIM Vaccine Co., Ltd.(a joint stock company incorporated in the People's Republic of China with limited liability)(Stock Code: 6660.HK) HONG KONG, Feb. 27, 2025 /PRNewswire/ -- The stocks in the Hong Kong pharmaceutical sector have recently shown an upward trend....

Yaber Shines at CES 2025 with Award-Winning K300s UST Laser Projector

LAS VEGAS, Jan. 14, 2025 /PRNewswire/ -- Yaber, a pioneer in entertainment projectors, has made a significant impact at CES 2025 with the unveiling...

Olight Donating Emergency Flashlights in Response to Los Angeles Wildfires

LOS ANGELES, Jan. 14, 2025 /PRNewswire/ -- Olight, the global leader in portable lighting solutions, donated 1,336 flashlights, valued at $56,830, in response to...

VIVOTEK’s “Safety Map” Expands to Eastern Taiwan, Boosting Community Safety with AI

TAIPEI, Jan. 13, 2025 /PRNewswire/ -- In 2024, Hualien, Taiwan experienced devastating earthquakes and typhoons, necessitating rebuilding efforts and tourism revitalization. VIVOTEK (3454-TW), the global...

DASI, LLC appoints new President as it continues to drive growth and strengthen leadership in the Aviation Aftermarket

Industry veteran Mike Heaton takes the helm to accelerate innovation and further enhance DASI, LLC's market position MIAMI, Jan. 13, 2025 /PRNewswire/ -- DASI, LLC,...

Delta Force Reveals Big Plans for 2025 Updates

New Release Windows for Mobile Version Announced Los Angeles, Jan. 13, 2025 /PRNewswire/ -- Today, Delta Force developer Team Jade revealed their plans for continuing...

BingX Expands DeFi Access with Exclusive Launchpad for SOLV Token

PANAMA CITY, Jan. 13, 2025 /PRNewswire/ -- BingX, a global leading cryptocurrency exchange, has announced the launch of SOLV token from Solv Protocol on BingX...